Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Financial planning is vital for a successful retirement. Discover the reasons why it matters for your long-term financial health.
24,228 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A single year's price move and a wave of AI demand have rewritten the memory market narrative. This article explains ...
When micron stock just dropped, it sparked questions about the memory market and Micron's long-term roadmap. This gui...
A prominent hedge fund just sold its entire XPeng stake, triggering questions for everyday investors. Learn how to ev...
A rare setup has investors watching for a pattern not seen since 1871. This article explains what the stock market br...
Alphabet is famous for growth, not income. A new high-yield option—mandatory convertible preferred shares GOOGM and G...
A top hedge fund boss reshapes his bets this quarter, exiting Chipotle and backing a two-sector powerhouse. Learn wha...
A scammer used a fake online romance to drain a senior’s savings, underscoring urgent fraud risks for older adults. L...
A shadowy hosting network in Russia reportedly kept cybercrime online, driving millions in losses. This guide explain...
A notable hedge fund just put $20 million into BlackLine. Is this the spark a turnaround scenario needs, or a cautiou...
Blink Charging's Q1 2026 earnings set the tone for the year. This article breaks down what to watch, how to read the ...
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...